NASDAQ: ELYM - Eliem Therapeutics, Inc.

Lønnsomhet i seks måneder: +89.59%
Sektor: Healthcare

Kampanjeplan Eliem Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial.

Flere detaljer
The company was incorporated in 2018 and is headquartered in Redmond, Washington.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0019
EV/EBITDA 10.99
IPO date 2021-08-10
ISIN US28658R1068
Industry Biotechnology
P/BV 1.64
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://eliemtx.com
Цена ао 2.71
Число акций ао 0.02699 млрд
Prisendring per dag: -0.1957% (5.11)
Prisendring per uke: +2% (5)
Prisendring per måned: -29.56% (7.24)
Prisendring over 3 måneder: -23.08% (6.63)
Prisendring over seks måneder: +89.59% (2.69)
Prisendring per år: +101.58% (2.53)
Prisendring over 3 år: -69.33% (16.63)
Prisendring siden begynnelsen av året: +99.22% (2.56)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.7136 10
P/E 0 0
EV/EBITDA 0.3969 10
Total: 5

Effektivitet

Navn Betydning Karakter
ROA, % -31.79 0
ROE, % -32.64 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0087 10
Total: 9.2

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 2019.74 10
Lønnsomhet EPS, % 134.3 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
RA Capital Management, L.P. 13150849 47.44
Bml Capital Management, LLC 2180000 7.86
Driehaus Capital Management, LLC 811680 2.93
Vanguard Group Inc 310486 1.12
Atom Investors LP 78276 0.28
Geode Capital Management, LLC 66626 0.24
Bridgeway Capital Management, Inc. 55223 0.2
Northern Trust Corporation 48712 0.18
Blackrock Inc. 31145 0.11
Tudor Investment Corporation 29490 0.11

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Avantis U.S Small Cap Equity ETF 0.00871 27.774101036841 1.68271
Dimensional U.S. Core Equity 2 ETF 0.00015 30.755198832543 1.47098
ProShares Hedge Replication ETF 0.00037 5.9237999659878 1.47892
iShares Neuroscience and Healthcare ETF 0.8148 19.720292847757 0.03
iShares Micro-Cap ETF 0.06271 29.340359461748 1.54048
iShares Russell 2000 Growth ETF 0.00105 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00133 89.821266282945 1.47873
Vanguard Russell 2000 ETF 0 30.781541744465 1.48801



Veileder Stillingstittel Betaling Fødselsår
Ms. Emily Pimblett Chief Accounting Officer N/A 1984 (40 år)
Ms. Jo Palmer-Phillips Ph.D. Chief Development Officer N/A
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc CEO, President & Director 1976 (48 år)
Dr. Brett Kaplan M.B.A., M.D. COO & Principal Financial Officer 1974 (50 år)
Dr. Nishi Rampal M.D. Senior Vice President of Clinical Development

Adresse: United States, Redmond. WA, 23515 NE Novelty Hill Road - åpne i Google maps, åpne Yandex-kart
Nettsted: https://eliemtx.com